Compare TKC & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TKC | TFX |
|---|---|---|
| Founded | 1993 | 1943 |
| Country | Turkey | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.8B |
| IPO Year | 2001 | 1994 |
| Metric | TKC | TFX |
|---|---|---|
| Price | $5.46 | $137.17 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $138.75 |
| AVG Volume (30 Days) | ★ 2.6M | 519.7K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.52% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.08 |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | $31.20 | $15.97 |
| Revenue Next Year | $24.27 | $5.15 |
| P/E Ratio | ★ $26.98 | $66.13 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.29 | $100.18 |
| 52 Week High | $7.18 | $145.00 |
| Indicator | TKC | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 54.08 |
| Support Level | N/A | $129.02 |
| Resistance Level | $5.73 | $137.40 |
| Average True Range (ATR) | 0.10 | 4.96 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 43.42 | 44.74 |
Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Techfin, and Other. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.